REGISTERED NUMBER: 03596334 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

LINDARE MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

Report of the Accountants

8

DIRECTORS:

M Kyne

A Kyne

SECRETARY:

M Kyne

REGISTERED OFFICE:

45 Queen Street

Deal

Kent

CT14 6EY

REGISTERED NUMBER:

03596334 (England and Wales)

ACCOUNTANTS:

Higson & Co (Deal) Ltd

45 Queen Street

Deal

Kent

CT14 6EY

FIXED ASSETS

Tangible assets

4

-

13,150

Investments

5

32,450

32,450

32,450

45,600

CURRENT ASSETS

Stocks

6

242,581

299,920

Debtors

7

295,587

442,830

Cash at bank and in hand

332,541

112,721

870,709

855,471

CREDITORS

Amounts falling due within one year

8

415,169

213,827

NET CURRENT ASSETS

455,540

641,644

TOTAL ASSETS LESS CURRENT LIABILITIES

487,990

687,244

CAPITAL AND RESERVES

Called up share capital

72

100

Capital redemption reserve

28

-

Retained earnings

487,890

687,144

SHAREHOLDERS' FUNDS

487,990

687,244

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 October 2025 and were signed on its behalf by:

M Kyne - Director

A Kyne - Director

1.	STATUTORY INFORMATION

Lindare Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates and value added tax.

Revenue from the sale of medical goods is recognised when all the risks and rewards of the ownership are transferred.

Revenue from the hire of equipment is recognised over the period of the hire period.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

10% on cost and 10% on reducing balance

Plant and machinery

-

20% on cost

Fixtures and fittings

-

25% on reducing balance and 10% on cost

Computer equipment

-

33% on cost and 25% on reducing balance

Tangible fixed assets are tested for impairment annually.

It is the Company's policy to capitalise items with an estimated useful life in excess of two years, and for

amounts in excess of £350.

A full year of depreciation is charged in the year of acquisition.

Investments in subsidiaries

Investments in Subsidiaries and Associates are shown at Fair Value.

Stocks

Stocks are valued at fair value less costs to sell, after making due allowance for obsolete and slow moving stock.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

Plant and

and

Computer

property

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 April 2024

and 31 March 2025

15,163

609,944

13,026

22,962

661,095

DEPRECIATION

At 1 April 2024

15,163

596,794

13,026

22,962

647,945

Charge for year

-

13,150

-

-

13,150

At 31 March 2025

15,163

609,944

13,026

22,962

661,095

NET BOOK VALUE

At 31 March 2025

-

-

-

-

-

At 31 March 2024

-

13,150

-

-

13,150

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 April 2024

and 31 March 2025

32,450

NET BOOK VALUE

At 31 March 2025

32,450

At 31 March 2024

32,450

The Company owns 65% of the share capital of Polar Medical Limited.

6.

STOCKS

2025

2024

£

£

Stocks

242,581

299,920

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

217,314

356,429

Other debtors

75,697

73,464

VAT

-

757

Prepayments

2,576

12,180

295,587

442,830

Other debtors represents an amount due from a subsidiary. Interest accrues throughout the year.

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

122,069

187,362

Tax

18,537

18,705

Social security and other taxes

2,612

2,442

VAT

17,779

-

Other creditors

1,473

1,138

Directors' current accounts

132,143

1,240

Accrued expenses

120,556

2,940

415,169

213,827

9.	RELATED PARTY DISCLOSURES

Polar Medical Limited - Related Party

Polar Medical Limited is a subsidiary by virtue of control.

During the year Lindare Medical Limited advanced Polar Medical Limited £Nil (2024: £Nil).

During the year Polar Medical Limited repaid Lindare Medical Limited £Nil (2024: £200,000

During the year interest was charged of £2,233 (2024: £7,586)

As at the 31 March 2025, the balance owing from Polar Medical Limited amounted to £75,697 (2024:

£73,464.

The heads of terms for the related party loan are;

Interest accrues at 3% per annum, and is repayable on demand.

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 March 2025 set out on pages one to twelve and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.

Higson & Co (Deal) Ltd

45 Queen Street

Deal

Kent

CT14 6EY

17 October 2025